IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cartesian Therapeutics Inc (SELBUSD)

CUSIP: 816212104 | X1 | 274 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AMurat Kalayoglu
with Seven One Eight Three Four Irrevocable Trust, Elizabeth Hoge, Sinan Kalayoglu
5,833,97119.9%New 5%+ stakeMar 31, 2026No 13F filer matched
13D/AMurat Kalayoglu5,833,971
19.9% of class · Mar 31, 2026New 5%+ stake
with Seven One Eight Three Four Irrevocable Trust, Elizabeth Hoge, Sinan Kalayoglu
No 13F filer matched

Institutional Holders — Q2 2024

MetLife Investment Management, LLC410
0.0% of portfolio›$11.1K
Osaic Holdings, Inc.62
0.0% of portfolio›$31
CWM, LLC4
0.0% of portfolio›$0
StyleTurnoverLocationFiled
MetLife Investment Management, LLC
410$11.1K0.0%CoreLowWhippany, NJ2024-08-13
Osaic Holdings, Inc.
62$310.0%IndexLowScottsdale, AZ2024-08-13
CWM, LLC
4$00.0%GrowthVery LowOmaha, NE2024-07-10